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AbstrAct
Objective
To evaluate the association between intakes of 
refined grains, whole grains, and white rice with 
cardiovascular disease, total mortality, blood lipids, 





PURE study in 21 countries.
ParticiPants
148 858 participants with median follow-up of 9.5 
years.
exPOsures
Country specific validated food frequency 
questionnaires were used to assess intakes of refined 
grains, whole grains, and white rice.
Main OutcOMe Measure
Composite of mortality or major cardiovascular events 
(defined as death from cardiovascular causes, non-
fatal myocardial infarction, stroke, or heart failure). 
Hazard ratios were estimated for associations of grain 
intakes with mortality, major cardiovascular events, 
and their composite by using multivariable Cox 
frailty models with random intercepts to account for 
clustering by centre.
results
Analyses were based on 137 130 participants after 
exclusion of those with baseline cardiovascular 
disease. During follow-up, 9.2% (n=12 668) of these 
participants had a composite outcome event. The 
highest category of intake of refined grains (≥350 g/
day or about 7 servings/day) was associated with 
higher risk of total mortality (hazard ratio 1.27, 95% 
confidence interval 1.11 to 1.46; P for trend=0.004), 
major cardiovascular disease events (1.33, 1.16 to 
1.52; P for trend<0.001), and their composite (1.28, 
1.15 to 1.42; P for trend<0.001) compared with the 
lowest category of intake (<50 g/day). Higher intakes 
of refined grains were associated with higher systolic 
blood pressure. No significant associations were 
found between intakes of whole grains or white rice 
and health outcomes.
cOnclusiOn
High intake of refined grains was associated with 
higher risk of mortality and major cardiovascular 
disease events. Globally, lower consumption of 
refined grains should be considered.
Introduction
Diet may influence the development and progression 
of chronic diseases.1 2 Globally, over the past few 
decades, the consumption of refined grains and added 
sugars has increased. Positive associations between 
higher consumption of refined carbohydrates with 
high glycaemic load and risk factors for cardiovascular 
disease have been reported.3
We previously showed that higher intake of 
carbohydrate was associated with higher risk of total 
mortality and cardiovascular disease,4 which was 
also reported by Ho et al.5 Cereal grains contribute 
approximately 50% of caloric intake across the world, 
with higher levels in low income and middle income 
countries, particularly in Africa and South Asia. In 
these regions, cereal grains contribute about 70% of 
daily caloric intake.6 Therefore, a detailed examination 
of the association between the types of cereal grains 
and health outcomes is warranted.
Several prospective cohort studies and their meta-
analyses have reported that higher consumption of 
whole grain is associated with a lower risk of mortality 
and cardiovascular disease.7-11 The association of 
refined grains with total mortality and cardiovascular 
disease has not been clearly defined. Meta-analyses 
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WhAt Is AlreAdy knoWn on thIs topIc
Among cereals that largely contribute to carbohydrate intake, higher 
consumption of whole grains has been associated with lower risk of total 
mortality and cardiovascular disease
However, no clear associations have been observed between refined grains and 
these outcomes
WhAt thIs study Adds
The Prospective Urban and Rural Epidemiology study includes participants from 
low, middle, and high income countries, covering broad patterns of diet globally
A higher intake of refined grains was associated with a higher risk of total 
mortality and major cardiovascular disease
No associations with the outcomes were found for whole grains or white rice
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have found different results, with two showing no 
association and another a positive association.12-14
Previous studies have been conducted mostly in 
North America and Europe, with limited information 
from other parts of the world where the amount and 
types of carbohydrates consumed in the diet vary, 
as do their contribution to overall calories. Studies 
in single geographical regions provide information 
on associations across a relatively limited range of 
intake. The Prospective Urban Rural Epidemiology 
(PURE) study has the distinct advantage of examining 
diets from diverse populations in low, middle, and 
high income countries in multiple regions across the 
world. The analysis reported here was conducted to 
evaluate the association of intake of refined grains, 
whole grains, and white rice with total mortality, major 




The PURE study is a large prospective cohort study 
conducted in countries across the regions of North 
America and Europe, South America, Africa, the 
Middle East, South Asia, South East Asia, and China. 
The design and sampling for the study have been 
published elsewhere.15 16 Data on people aged 35 to 
70 years at baseline were collected from 21 countries—
five low income countries, five lower middle income 
countries, seven upper middle income countries, and 
four high income countries, as classified by the World 
Bank in 2006, covering urban and rural locations. 
Participants recruited from January 2003 and followed 
up until July 2019 were included in the analysis.
Data collection procedures
Baseline survey
Individual, household, and community level 
information was collected through questionnaires, 
using a standardised protocol across all countries 
at baseline. Details of demographic factors, socio-
economic status (education, income, employment), 
lifestyle behaviours (smoking, physical activity, 
diet, and alcohol intake), personal medical history 
including self-reported history of diabetes, use of 
medications, record of comorbidities (hypertension, 
cardiovascular disease, history of diabetes, etc), 
and risk factors were obtained. Physical activity was 
assessed using the long form of the International 
Physical Activity Questionnaire and categorised as 
low (<600 MET-minutes per week), moderate (600-
3000 MET-minutes per week), and high (≥3000 MET-
minutes per week). A standard protocol was used to 
take physical measurements of blood pressure and 
anthropometric measurements of weight, height, and 
waist and hip circumference.16 Blood samples were 
collected and blood lipid concentrations measured. 
Of the 148 858 participants, 129 740 (87%) had 
fasting blood samples and 3632 had non-fasting blood 
samples; we were unable to ascertain blood status for 
the rest.
Follow-up
Follow-up was conducted every three years. Data were 
collected at the community, household, and individual 
levels with standardised questionnaires administered 
by trained staff. Standard case report forms were used 
to record data on major cardiovascular events and 
mortality (classified by cause) during follow-up, which 
were adjudicated centrally in each country by trained 
physicians using common definitions, according to 
a standard protocol as previously described.4 The 
definitions of events are detailed in the methods 
section of the supplementary appendix. For this 
analysis, we included all adjudicated outcome events. 
The study was coordinated by the Population Health 
Research Institute (PHRI), Hamilton, Canada.
Dietary assessment
Each participant’s food intake was recorded at 
baseline using country specific (or region specific in 
India) validated food frequency questionnaires as 
previously described.4 17 Typically, the food lists for 
food frequency questionnaires contained between 
98 and 220 food items across the various countries. 
Interviewers asked participants: “During the past 
year, on average, how often have you consumed the 
following foods or drinks.” The format of the food 
frequency questionnaire remained similar for all 
countries, with options of frequencies ranging from 
never to more than six times a day. Portion sizes were 
assigned to each food item on the list. We calculated 
the daily food intake of each participant by multiplying 
the daily frequency of intake by the portion size.
exposures
The main exposures were the consumption of refined 
grains, whole grains, and white rice. For this analysis, 
we categorised grains into three groups: refined grains, 
whole grains, and white rice. We examined white rice 
separately from all other refined grains because more 
than 60% of the PURE population reside in Asia where 
rice is a staple food. The three grain food categories 
were mutually exclusive. The definitions used for the 
grain categories were as follows.
We defined refined grains as wheat grain products 
or flours that have been modified to remove the bran 
(the aleurone layer) and germ and therefore have a 
low fibre content. Products in this category are made 
with refined (white) flour, including white bread, 
pasta/noodles, breakfast cereals, crackers, and bakery 
products/desserts containing refined grains. For 
bakery products and desserts, we counted only the 
proportion of refined grains. Ready to eat breakfast 
made from corn was also included in this group.
The whole grains group contained two types of 
grains. The first was whole grain flours such as those 
made from wheat, rye, triticale, oats, barley, maize, 
finger and pearl millet, sorghum, or buckwheat. 
Wheat products made from flours ideally contain all 
the components of the intact grain (whole meal). This 
applies to all flours that are produced as “stone ground 
flours”—that is, where millstones, the traditional 
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method of making grain flours, are used to grind 
flours. With the onset of industrialisation, flours were 
produced by steel roller mills. In this case, a “white” 
flour is produced and the germ (lipid) and aleurone 
layer that contains fibre and protein are separated. 
The germ, containing the lipid, is then heat treated 
to prevent rancidity. The bran (that is, the aleurone 
fibre layer), the heat treated germ, and the “white” 
flour are recombined in various proportions to reflect 
their proportion in the intact grain (for example, 25%, 
50%, 75%, or 100% of the germ and aleurone layer). 
This percentage is the extraction rate. As the method 
of processing is unknown (for example, stone mill or 
steel roller), we refer to all flours with some increased 
fibre, over and above the “white flour” content, as 
whole grain flour. The second type of grain in this 
group is intact or “cracked” whole grains and whole 
grain porridges—whole grains that are still associated 
with their fibre, such as pumpernickel breads, cracked 
wheat, bulgur, steel cut oats, barley, and oat and maize 
porridges. The whole grain definition also includes 
whole corn and cornmeal and dark bread but excludes 
corn products such as popcorn. Intake of popcorn as a 
snack was recorded only in Brazil and Canada.
In white rice, the grain has been left recognisably 
intact but processed to remove the protein and fibre 
aleurone layer and the germ to make it “white” but 
visually “intact.” In other words, it is milled rice from 
which the husk, bran, and germ have been removed. 
Ready to eat breakfast made of rice was also included 
in this group. In the PURE study, we were unable to 
differentiate between regular white rice and parboiled 
white rice, which contains more of the nutrients 
associated with brown rice and is more slowly digested 
and accordingly has a lower glycaemic index. Brown 
rice consumption was captured only in Argentina 
and Brazil, where its intake was very low (2 g/day in 
Argentina and 16 g/day in Brazil). Therefore, brown 
rice was not included in any grain group.
For each centre, all food containing grains or mixed 
dishes with grains were identified. All food frequency 
questionnaires combined gave a total list of 566 refined 
grain, 207 whole grain, and 176 white rice items. For 
mixed dishes, we considered the proportion of grains 
constituting the cooked portion in a recipe while 
calculating the grain intake in grams for each person. 
We grouped participants on the basis of their range of 
intakes into five categories for refined grains (<50, 50 
to <150, 150 to <250, 250 to <350, and ≥350 g/day), 
four categories for whole grains (0, <50, 50 to <100, 
and ≥100 g/day), and five categories for white rice (<50, 
50 to <150, 150 to <300, 300 to <450, and ≥450 g/day). 
The categorisation for each grain was based on a 100 
g increase, except for white rice, for which an increase 
of 150 g per day (a cup of cooked rice) was considered. 
Furthermore, for the categorisation of white rice, as a 
large proportion of participants reported intakes below 
150 g per day, intakes below 150 g were separated into 
two categories. For refined grains, the highest category 
of 350 g/day or more represented about seven to 10 
servings per day mainly as white bread, whole grain 
intake of 100 g/day or more represented at least three 
servings per day, and 450 g/day or more of white rice 
represented at least six servings of cooked rice per day.
To calculate the raw value of whole grain, we 
calculated dry matter for whole grain foods at the 
region level. The calculations for dry weight used 
a coefficient for the water content. Thus, for North 
America/Europe, South America, and the Middle 
East, it was 30%, as the main source of whole grain 
was whole wheat bread.18 It was 50% for Africa, with 
porridges mostly being consumed, 35% for South 
Asia and South East Asia, and 40% for China (based 
on some of the main whole grain recipes from these 
regions). For dry weight, we categorised whole grains 
as 0, less than 10, 10-19.9, 20-29.9, and at least 
30 g/day. The serving sizes for each country were also 
calculated as per the US Department of Agriculture.
We used the lowest category of intake for refined 
grain and white rice and the highest category for 
whole grains as the reference categories. Participants 
with plausible energy intakes (500-5000 kcal/day) 
were included in the analysis.4
Outcomes
The primary outcome of this analysis was the 
composite of mortality or major cardiovascular disease 
events (defined as death from cardiovascular causes, 
non-fatal myocardial infarction, stroke, or heart 
failure). Secondary outcomes were total mortality, 
and major cardiovascular disease (fatal and non-fatal 
myocardial infarction, fatal and non-fatal stroke, heart 
failure, and cardiovascular mortality). Other outcomes 
measured were blood lipids (total cholesterol, high 
density lipoprotein cholesterol, low density lipoprotein 
cholesterol, total cholesterol to high density lipoprotein 
cholesterol ratio, triglycerides, apolipoprotein A1, 
apolipoprotein B, apolipoprotein B to apolipoprotein 
A1 ratio) and blood pressure measured at baseline.
statistical analysis
We summarised continuous measurements by using 
mean and standard deviation if normally distributed; 
otherwise, we used medians and interquartile ranges. 
We present categorical observations as frequency 
and percentages. We created a wealth index by using 
information collected on household possessions such 
as electricity, car, computer, television, and telephone. 
We created a binary yes/no classification for each 
item and then used a principal component analysis 
to extract the component with the largest eigenvalue. 
We then assigned each household to a score based 
on factor loadings. We categorised education as none 
or primary school (first six years), secondary school 
(seven to 11 years), and college, trade school, or 
university (>11 years); smoking as never, former, or 
current; and physical activity as low (<600 MET-min 
per week), moderate (600-3000 MET-min per week), 
and high (>3000 MET-min per week) activity.
We evaluated the proportional hazards assumption 
by visual inspection of log-log plots, which were 
consistent with proportional hazards. We assessed 
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the association between types of grain intake and 
the time to occurrence of events by using a Cox 
frailty model with random intercepts to account for 
clustering by centres (which simultaneously adjusts 
for region and country). We assumed that frailty 
followed a γ distribution with correlated observations 
within cluster. We estimated hazard ratios for both the 
univariate base model and the multivariable adjusted 
model and presented them as hazard ratios and 95% 
confidence intervals. We excluded participants with 
history of cardiovascular disease at baseline. For all 
analyses on associations, we adjusted total energy 
intake by using a standard multivariable model, as the 
study examined the association between food intake 
and clinical outcomes.19 20 We identified covariates a 
priori, on the basis of the literature,17 21-28 as those that 
were associated with at least one of the events listed 
and are potential confounders in the association of 
grains with events. We also included fruit and vegetable 
intake as a covariate, as these are a major source of 
fibre. We used one way analysis of variance to examine 
the association of wealth index, age, waist to hip ratio, 
and intakes of total energy, fruits and vegetable, and 
unprocessed red meat with grain intake. We used 
Pearson’s χ2 test for categorical variables such as sex, 
location (urban/rural), education, smoking, physical 
activity, and history of diabetes (yes/no). As previous 
food frequency questionnaire validation studies have 
shown that the error of variance for sodium is high,29 
we did not include dietary sodium as a covariate in 
our models. However, an analysis with adjustment 
for saturated fat and sodium is also presented in the 
supplementary material. We did not include alcohol 
intake in the model, as this was not captured in 
five Muslim countries (Bangladesh, Iran, Pakistan, 
Malaysia, and United Arab Emirates). Soft drink intake 
in low and middle income countries (except Argentina) 
was low, so intake of sugar sweetened drinks was not 
included as a covariate in the models. To evaluate 
whether history of diabetes could be a mediator, we 
analysed data with and without diabetes included in 
the model. Considering the biology and the causal 
pathway, no colliders were included.
The base model was adjusted for age and sex, with 
centre considered as a random effect. The minimally 
adjusted model included the base model with further 
adjustment for location (urban/rural), education, 
wealth index, smoking status, waist to hip ratio, 
physical activity, history of diabetes, energy intake, 
fruit and vegetable intake, and dairy intake. The fully 
adjusted model additionally included refined or whole 
grain intake as appropriate, as grains are eaten in 
combination. This also allows for adjustment for fibre 
from other cereal sources. The main results reported 
are on the basis of the fully adjusted models. We did 
an additional analysis using the fully adjusted model 
with medications included (statins and blood pressure 
lowering drugs). We used restricted cubic splines 
with four knots (at the 5th, 35th, 65th, and 95th 
percentiles) to explore the shape of the association of 
grains with events.
We did a sensitivity analysis of the fully adjus-
ted model by excluding participants who had 
cardiovascular disease events in the first two years of 
follow-up to account for possible reverse causation. To 
account for the clustering of intakes within region, we 
performed the Cox proportional hazards models with 
frailty separately within high and low intake regions 
for refined grains. Low intakes regions were Africa and 
South Asia, where median intakes were below 100 g, 
and the remaining regions had high intakes. The whole 
grain intake in Africa was much higher than in the rest 
of the regions, so we did a sensitivity analysis that 
excluded data from Africa and explored the association 
of whole grains and outcomes. To further account for 
the clustering of grain intake by region, we estimated 
hazard ratios by region and obtained an overall 
estimate by meta-analysis. To examine heterogeneity 
of the associations of grains with major cardiovascular 
disease and mortality by geographical region, we did a 
random effects meta-analysis across all regions. Tests 
of heterogeneity used the I2 statistic.
We could not do subgroup analyses for the Africa 
region for estimate of composite outcome, total mor-
tality, and major cardiovascular disease events for 
refined grain, whole grain, and white rice consumption 
and for South East Asia for estimation of total mortality 
for refined grain consumption alone, as the sample 
size in these regions was insufficient for hazard ratio 
estimation. Additionally, we did a subgroup analysis 
in the Asian regions (South Asia, South East Asia, and 
China), where consumption of rice was higher than 
in non-Asian regions. We also present results with 
serving size per day as a continuous variable for each 
grain type. We did further subgroup analyses to assess 
associations of grains with major cardiovascular 
disease events and mortality by country income level 
(high, middle, and low income countries), body mass 
index (<25 and ≥25), and sex, with tests for interaction.
We also analysed whole grains alone with the raw 
quantities of whole grains calculated for each region. The 
results of analysis using serving sizes are also reported.
To examine the association of grain intake with 
blood pressure and blood lipids, we used multilevel 
linear regression with random effect models adjusted 
for centre. For all comparisons, the criterion for the P 
value to be considered significant was at the 5% level. 
We used Stata version 14 for all analyses.
Patient and public involvement
Patients and the public were not formally involved in 
setting the research question or the outcome measures; 
nor were they involved in developing plans for 
recruitment, design, or implementation of the study. 
No patients were asked to advise on interpretation 
or writing up of results. At each site, community 
leaders were informed about the study plans to 
motivate their community to participate in the study. 
Each participating centre provided results of clinical 
tests such as electrocardiography and spirometry at 
baseline and follow-up visits along with information 
about the progress of the study.
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results
Data were available for 148 858 participants. Of these, 
11 728 with baseline cardiovascular disease were 
excluded from analysis, leaving 137 130 for analysis. 
The rate of follow-up was 94% over the median follow-
up duration of 9.5 (interquartile range 8.6-10.9) 
years. The follow-up period and rate for each country 
are provided in supplementary table S1. During 
this period, 10.3% (n=15 251) of participants had a 
composite outcome event. Of the total of 9279 deaths, 
3583 (38.6%) were due to cardiovascular disease. 
Major cardiovascular disease events (myocardial 
infarction, stroke, heart failure) were recorded in 8833 
(5.9%) participants. The flowchart of recruitment is 
provided in the supplementary appendix.
The consumption of refined grains was highest 
in China followed by South East Asia, and intake of 
white rice was highest in South Asia. Countries in 
Africa reported the highest intake of whole grains 
(table 1). All covariates considered were significantly 
associated with grain intake and were considered in 
the fully adjusted models (supplementary tables S2-
S4; all P<0.001). The models were first tested with and 
without adjustment of diabetes (supplementary tables 
S5-S7) for each of the grains, and the results were not 
different; therefore, we did not consider the presence 
of diabetes as a mediator in the association between 
grains and outcome and we included it in multivariable 
adjustment.
Table 2 shows the association of refined grain 
consumption and risk of various clinical outcomes. 
In the fully adjusted model, compared with low 
intake, a higher level of intake (<50 g/day v >350 g/
day) was significantly associated with higher risk 
of the composite outcome (hazard ratio 1.28, 95% 
confidence interval 1.15 to 1.42; P for trend <0.001), 
total mortality (1.27, 1.11 to 1.46; P for trend=0.004), 
non-cardiovascular mortality (1.31, 1.10 to 1.56; P 
for trend=0.004), major cardiovascular disease events 
(1.33, 1.16 to 1.52; P for trend <0.001), and stroke (1.47, 
1.22 to 1.77; P for trend<0.001). For a 50 g increase in 
refined grain intake, the hazard ratio for the composite 
outcome of total mortality and major cardiovascular 
disease events was 1.02 (1.01 to 1.03). We noted no 
significant associations with cardiovascular disease 
mortality, myocardial infarction, and heart failure. 
These associations were unchanged after adjustment 
for medications (table 2). We found significant 
positive associations in high intake regions, but not 
in low intake regions, for composite events, total 
mortality, and major cardiovascular disease (fig 1; 
supplementary table S8; all P for interaction>0.05). 


















Mean (SD) age, years 50.1(9.9) 52.1(9.2) 51.0 (9.6) 49.8 (10.6) 47.5 (9.2) 48.1 (10.2) 51.6 (9.8) 50.5 (9.7)
Male sex 57 101 (41.6) 7572 (43.0) 8318 (38.5) 1760 (30.3) 4553 (48.3) 12 746 (43.6) 4746 (40.2) 17 406 (41.9)
Urban 72 422 (52.8) 12 261 (69.6) 12 243 (56.6) 2884 (49.6) 5448 (57.8) 14 103 (48.2) 5601 (47.4) 19 882 (47.8)
Current smoker 28 478 (20.8) 3123 (17.8) 4533 (21.1) 1385 (24.2) 1388 (14.7) 6708 (23.1) 1824 (15.6) 9517 (23.1)
History of diabetes 9784 (7.1) 1050 (6.0) 1412 (6.5) 261 (4.5) 1395 (14.8) 2662 (9.1) 1436 (12.2) 1568 (3.8)
Physical activity: (n=127 692) (n=16 345) (n=20 648) (n=3452) (n=9333) (n=25 719) (n=11 193) (n=41 002)
 Low 23 041 (18.0) 1473 (9.0) 2770 (13.4) 695 (20.1) 2956 (31.7) 5520 (21.5) 3271 (29.2) 6356 (15.5)
 Moderate 47 833 (37.5) 6053 (37.0) 6609 (32.0) 1283 (37.2) 3966 (42.5) 8784 (34.2) 3850 (34.4) 17 288 (42.2)
 High 56 818 (44.5) 8819 (54.0) 11 269 (54.6) 1474 (42.7) 2411 (25.8) 11 415 (44.4) 4072 (36.4) 17 358 (42.3)
Mean (SD) nutrient intake/day:
 Energy, kcal 2155 (819) 2275 (834) 2213 (798) 2042 (950) 2340 (835) 2109 (828) 2521 (1008) 1977 (667)
  Energy from  
carbohydrate, % 61.1 (11.6) 51.7 (8.2) 57.6 (11.4) 61.2 (11.3) 55.7 (6.5) 65.4 (11.3) 54.5 (8.5) 67.0 (9.8)
 Energy from fat, % 23.7 (9.4) 31.07 (6.2) 25.2 (7.7) 25.2 (8.9) 28.8 (5.4) 22.7 (10.5) 28.9 (6.5) 17.7 (7.8)
 Energy from protein, % 15.2 (3.6) 16.6 (2.7) 17.5 (3.8) 13.79 (3.1) 17.4 (2.7) 11.61 (1.9) 16.7 (3.4) 15.3 (2.8)
Median (IQR) food intake, g/d:
 Refined grains 116 (46-226) 109 (62-184) 124 (72-204) 82 (34-139) 144 (85-195) 30 (8-84) 157 (95-262) 225 (72-455)
 Whole grains 35 (2-143) 70 (28 146) 21 (1-7.4) 394 (195-771) 17 (0-72) 53 (11-202) 3 (0-14) 38 (0-163)
 White rice 129 (38-401) 23 (8-38) 68 (23-158) 60 (23-96) 108 (74-182) 612 (110-948) 229 (115-389) 200 (59-600)
 Fruits 143 (52-313) 334 (201-520) 328 (166-596) 147 (46-313) 320 (210-505) 46 (15-113) 175 (93-281) 84 (41-162)
 Vegetables 250 (126-279) 310 (181-498) 287 (163-469) 148 (72-282) 255 (183-339) 122 (64-220) 174 (93-261) 251 (218-257)
 Red meat 43 (11-98) 82 (49-120) 90 (46-148) 47 (17-101) 78 (45-126) 1 (0.0-10) 21 (10-42) 52 (22-101)
Events:
 Composite events 12 668 (9.2) 1171 (6.6) 1586 (7.3) 800 (13.8) 378 (4.0) 4139 (14.2) 1105 (9.4) 3489 (8.4)
 Total mortality 7821 (5.7) 552 (3.1) 1105 (5.1) 620 (10.7) 155 (1.6) 3046 (10.4) 784 (6.6) 1559 (3.7)
  Non-cardiovascular  
mortality 5406 (3.9) 460 (2.6) 788 (3.6) 496 (8.5) 105 (1.1) 2035 (7.0) 563 (4.8) 959 (2.3)
 Cardiovascular mortality 2777 (2) 100 (0.6) 358 (1.7) 210 (3.6) 51 (0.5) 1125 (3.8) 294 (2.5) 639 (1.5)
  Major cardiovascular  
disease 6898 (5.0) 734 (4.2) 800 (3.7) 245 (4.2) 265 (2.8) 1830 (6.3) 496 (4.2) 2528 (6.1)
 Myocardial infarction 2999 (2.2) 361 (2.0) 402 (1.9) 48 (0.8) 159 (1.7) 1152 (7.0) 215 (1.8) 662 (1.6)
 Stroke 3227 (2.4) 263 (1.5) 272 (1.3) 95 (1.6) 87 (0.9) 566 (14.2) 192 (1.6) 1752 (4.2)
 Heart failure 656 (0.5) 114 (0.6) 131 (0.6) 65 (1.1) 32 (0.3) 99 (10.4) 71 (0.6) 144 (0.3)
IQR=interquartile range.
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The associations between refined grains and clinical 
outcomes after grouping of participants into fifths of 
intake also showed that higher intake of refined grains 
was associated with higher risk of clinical outcomes 
(supplementary table S9).
Table 3 shows associations between whole grains 
and health outcomes. We found non-significant 
associations between intake of whole grains and risk of 
mortality or cardiovascular events in the fully adjusted 
models. In the base model, we observed a higher risk of 
composite events, total mortality, non-cardiovascular 
mortality, cardiovascular mortality, major cardio-
vascular disease, and stroke in participants with no 
whole grain intake. The association remained the 
same in the sensitivity analysis with the African region 
excluded from the analysis (supplementary table S10). 
table 2 | association between refined grain intake and clinical outcomes in participants (n=135 260) without baseline cardiovascular disease
Hazard ratio (95% ci)*
P for trend
<50 g/d  
(n=35 665)†
50 to <150 g/d 
(n=44 015)‡
150 to <250 g/d 
(n=25 507)§
250 to <350 g/d 
(n=12 133)¶
≥350 g/d  
(n=17 940)**
composite events
No (%) events 3903 (10.9) 3686 (8.4) 1938 (7.6) 1016 (8.4) 1778 (9.9)
Base model 1.00 (reference) 0.97 (0.91 to 1.02) 0.93 (0.87 to 0.99) 0.97 (0.89 to 1.05) 1.12 (1.03 to 1.21) 0.05
Minimally adjusted 1.00 (reference) 1.07 (1.01 to 1.15) 1.11 (1.03 to 1.20) 1.16 (1.05 to 1.28) 1.27 (1.14 to 1.41) <0.001
Fully adjusted 1.00 (reference) 1.07 (1.01 to 1.14) 1.11 (1.03 to 1.21) 1.17 (1.05 to 1.29) 1.28 (1.15 to 1.42) <0.001
Fully adjusted with medications 1.00 (reference) 1.08 (1.01 to 1.15) 1.12 (1.03 to 1.21) 1.18 (1.06 to 1.30) 1.29 (1.16 to 1.43) <0.001
total mortality
No (%) events 2703 (7.6) 2289 (5.2) 1122 (4.4) 532 (4.4) 878 (4.9)
Base model 1.00 (reference) 0.91 (0.85 to 0.97) 0.87 (0.80 to 0.95) 0.85 (0.76 to 0.96) 1.08 (0.97 to 1.20) 0.84
Minimally adjusted 1.00 (reference) 1.04 (0.96 to 1.13) 1.08 (0.97 to 1.20) 1.04 (0.91 to 1.19) 1.26 (1.09 to 1.45) 0.006
Fully adjusted 1.00 (reference) 1.04 (0.96 to 1.13) 1.09 (0.98 to 1.21) 1.05 (0.91 to 1.20) 1.27 (1.11 to 1.46) 0.004
Fully adjusted with medications 1.00 (reference) 1.05 (0.96 to 1.14) 1.09 (0.98 to 1.21) 1.05 (0.92 to 1.21) 1.28 (1.11 to 1.47) 0.003
non-cardiovascular mortality
No (%) events 1907 (5.4) 1564 (3.6) 812 (3.2) 375 (3.1) 530 (3.0)
Base Model 1.00 (reference) 0.89 (0.83 to 0.97) 0.89 (0.81 to 0.99) 0.85 (0.74 to 0.97) 1.00 (0.88 to 1.14) 0.49
Minimally adjusted 1.00 (reference) 1.08 (0.98 to 1.19) 1.19 (1.05 to 1.35) 1.1 (0.94 to 1.30) 1.29 (1.08 to 1.53) 0.007
Fully adjusted 1.00 (reference) 1.08 (0.98 to 1.19) 1.19 (1.05 to 1.35) 1.12 (0.95 to 1.31) 1.31 (1.10 to 1.56) 0.004
Fully adjusted with medications 1.00 (reference) 1.08 (0.98 to 1.19) 1.20 (1.05 to 1.35) 1.12 (0.95 to 1.32) 1.31 (1.11 to 1.56) 0.003
cardiovascular mortality
No (%) events 904 (2.5) 851 (1.9) 358 (1.4) 179 (1.5) 384 (2.1)
Base model 1.00 (reference) 0.94 (0.83 to 1.05) 0.8 (0.69 to 0.93) 0.83 (0.69 to 1.01) 1.20 (1.00 to 1.43) 0.32
Minimally adjusted 1.00 (reference) 0.99 (0.86 to 1.14) 0.85 (0.71 to 1.02) 0.91 (0.72 to 1.14) 1.18 (0.94 to 1.47) 0.40
Fully adjusted 1.00 (reference) 0.99 (0.86 to 1.14) 0.85 (0.71 to 1.02) 0.9 (0.72 to 1.13) 1.17 (0.94 to 1.47) 0.44
Fully adjusted with medications 1.00 (reference) 0.99 (0.86 to 1.14) 0.86 (0.71 to 1.02) 0.92 (0.73 to 1.15) 1.18 (0.95 to 1.48) 0.36
Major cardiovascular disease
No (%) events 1774 (5.0) 2000 (4.5) 1127 (4.4) 654 (5.4) 1233 (6.9)
Base model 1.00 (reference) 1.08 (1.00 to 1.17) 1.03 (0.94 to 1.13) 1.12 (1.00 to 1.25) 1.25 (1.12 to 1.39) <0.001
Minimally adjusted 1.00 (reference) 1.11 (1.01 to 1.21) 1.13 (1.02 to 1.26) 1.25 (1.10 to 1.42) 1.32 (1.15 to 1.51) <0.001
Fully adjusted 1.00 (reference) 1.11 (1.01 to 1.21) 1.13 (1.02 to 1.26) 1.26 (1.10 to 1.43) 1.33 (1.16 to 1.52) <0.001
Fully adjusted with medications 1.00 (reference) 1.11 (1.02 to 1.21) 1.14 (1.03 to 1.27) 1.27 (1.12 to 1.45) 1.34 (1.17 to 1.53) <0.001
Myocardial infarction
No (%) events 874 (2.5) 983 (2.2) 485 (1.9) 229 (1.9) 360 (2.0)
Base model 1.00 (reference) 1.08 (0.97 to 1.21) 1.01 (0.88 to 1.16) 1.02 (0.85 to 1.22) 1.08 (0.91 to 1.29) 0.66
Minimally adjusted 1.00 (reference) 1.10 (0.96 to 1.25) 1.07 (0.91 to 1.26) 1.13 (0.92 to 1.39) 1.14 (0.92 to 1.42) 0.25
Fully adjusted 1.00 (reference) 1.10 (0.96 to 1.25) 1.07 (0.91 to 1.25) 1.12 (0.91 to 1.38) 1.12 (0.90 to 1.39) 0.35
Fully adjusted with medications 1.00 (reference) 1.10 (0.96 to 1.25) 1.07 (0.91 to 1.26) 1.13 (0.92 to 1.39) 1.13 (0.91 to 1.40) 0.30
stroke
No (%) events 751 (2.1) 774 (1.8) 519 (2.0) 369 (3.0) 797 (4.4)
Base model 1.00 (reference) 1.04 (0.93 to 1.17) 1.02 (0.89 to 1.17) 1.16 (0.99 to 1.36) 1.34 (1.15 to 1.57) <0.001
Minimally adjusted 1.00 (reference) 1.08 (0.94 to 1.23) 1.13 (0.96 to 1.32) 1.28 (1.07 to 1.54) 1.44 (1.20 to 1.74) <0.001
Fully adjusted 1.00 (reference) 1.07 (0.94 to 1.22) 1.13 (0.96 to 1.32) 1.29 (1.08 to 1.55) 1.47 (1.22 to 1.77) <0.001
Fully adjusted with medications 1.00 (reference) 1.07 (0.94 to 1.22) 1.13 (0.97 to 1.32) 1.30 (1.09 to 1.56) 1.47 (1.22 to 1.78) <0.001
Heart failure
No (%) events 129 (0.4) 244 (0.6) 150 (0.6) 57 (0.5) 72 (0.4)
Base model 1.00 (reference) 1.20 (0.94 to 1.52) 1.36 (1.04 to 1.77) 1.19 (0.83 to 1.69) 1.15 (0.81 to 1.65) 0.34
Minimally adjusted 1.00 (reference) 1.21 (0.92 to 1.59) 1.55 (1.13 to 2.12) 1.38 (0.92 to 2.07) 1.1 (0.71 to 1.72) 0.31
Fully adjusted 1.00 (reference) 1.22 (0.93 to 1.61) 1.59 (1.16 to 2.18) 1.43 (0.95 to 2.15) 1.16 (0.74 to 1.82) 0.22
Fully adjusted with medications 1.00 (reference) 1.22 (0.93 to 1.61) 1.60 (1.17 to 2.19) 1.46 (0.97 to 2.19) 1.17 (0.75 to 1.82) 0.19
*Cox frailty model. Base model: adjusted for age and sex, with centre as random effect; minimally adjusted: adjusted for age, sex, location (urban/rural), wealth index, education, smoking, waist-
hip ratio, physical activity, history of diabetes, and daily intakes of energy (kcal), vegetable and fruits, dairy, and red meats, with centre as random effect; fully adjusted: adjusted as for minimally 
adjusted plus whole grains, with centre as random effect; fully adjusted with medications: adjusted as for fully adjusted plus medications (statins and antihypertensives), with centre as random 
effect.
†Median (interquartile range (IQR) intake) 18.5 (7.0-32.9).
‡Median (IQR) intake 92.9 (72.0-118.9).
§Median (IQR) intake 185.9 (165.4-213.9).
¶Median (IQR) intake 300.0 (272.3-319.5).
**Median (IQR) intake 498.4 (450.0-675.0).
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We observed similar results when we used dry weight 
as measure of whole grain intake (supplementary table 
S11).
Higher intake of white rice (>450 g/day v <150 g/day) 
was not associated with any of the health outcomes in 
the fully adjusted models (table 4). Similar neutral 
associations existed between consumption of white 
rice and clinical events in Asian (high intake) and non-
Asian (low intake) countries (P>0.05 for composite 
events, total mortality, and major cardiovascular 
disease; fig 2 and supplementary table 12; P for 
interaction>0.05). In both the base and minimally 
adjusted models, higher intakes (≥450 g/day) of white 
rice were associated with lower risk of composite 
events, total mortality, non-cardiovascular mortality 
and major cardiovascular disease.
The inclusion of sodium and saturated fat intake 
into the models did not change the results for any type 
of grain (supplementary tables S13-S15). Likewise, 
excluding participants who had cardiovascular 
disease events in the first two years of follow-up 
did not change the results (supplementary tables 
S16-S18). Multivariable splines showed significant 
linear associations of higher consumption of re-
fined grains with total mortality but no significant 
associations between intake of whole grains or white 
rice and composite events, total mortality, and major 
cardiovascular disease (fig 3).
When we did a meta-analysis of region specific 
analyses, the overall associations between refined 
grain intake and clinical outcomes were not significant 
(hazard ratio 1.03 (0.96 to 1.09) for composite event 
(P for heterogeneity=0.001); 1.04 (0.98 to 1.10) for 
total mortality (P for heterogeneity=0.13); and 1.01 
(0.89 to 1.12) for major cardiovascular disease (P for 
heterogeneity <0.001)), but we observed a significant 
positive association for all three outcomes for China 
(supplementary figure S1A). Even when we examined 
the association for a 50 g increase in intake of refined 
grain, we saw a positive effect in China for all the three 
outcomes but not overall for all regions (supplementary 
figure S1B). Intakes of whole grain and rice were not 
associated with any of the outcomes (supplementary 
figure S1C, S1D).
When we examined intakes of refined and whole 
grains as servings per day (supplementary table S19), 
we observed similar results for refined grains and 
whole grains. Stratified analyses by high, middle, and 
low income countries showed similar associations 
among all income regions (P for interaction>0.05) 
(supplementary tables S20-S22). By contrast, we found 
significant heterogeneity by region for white rice for 
composite outcome events (P=0.001), total mortality 
(P=0.02), and major cardiovascular disease (P=0.003), 
with rice intake associated with events in middle and 
low income countries but not in high income countries 
(where there were fewer participants).
In analyses stratified by body mass index (≥25 and 
<25) (supplementary figures S2-S4), we found stronger 
associations between refined grain intake and total 
mortality in the lower body mass index group (<25) 
than in the group with body mass index of 25 or above 
(P for interaction=0.001). For whole grains, the risk 
of total mortality was higher among participants with 
Composite events
  <50 (reference)
  50 to <150
  150 to <250
  250 to <350
  ≥350
Total mortality
  <50 (reference)
  50 to <150
  150 to <250
  250 to <350
  ≥350
Major cardiovascular disease
  <50 (reference)
  50 to <150
  150 to <250
  250 to <350
  ≥350
1.00 (1.00 to 1.00)
1.02 (0.91 to 1.14)
0.95 (0.79 to 1.13)
1.03 (0.69 to 1.53)
1.31 (0.79 to 2.16)
1.00 (1.00 to 1.00)
0.97 (0.86 to 1.11)
0.93 (0.75 to 1.16)
1.03 (0.63 to 1.66)
1.54 (0.88 to 2.70)
1.00 (1.00 to 1.00)
0.92 (0.78 to 1.09)
0.81 (0.63 to 1.05)
0.78 (0.44 to 1.38)
1.18 (0.58 to 2.41)








1.00 (1.00 to 1.00)
1.13 (1.04 to 1.22)
1.20 (1.09 to 1.32)
1.24 (1.11 to 1.39)
1.35 (1.20 to 1.53)
1.00 (1.00 to 1.00)
1.11 (0.99 to 1.24)
1.17 (1.03 to 1.33)
1.10 (0.94 to 1.28)
1.28 (1.09 to 1.52)
1.00 (1.00 to 1.00)
1.18 (1.06 to 1.31)
1.25 (1.11 to 1.41)
1.40 (1.21 to 1.61)
1.51 (1.30 to 1.76)






Fig 1 | association between refined grain intake and clinical outcomes in high (n=102 075) and low (n=33 185) intake regions. cox frailty model 
hazard ratios and 95% cis in model fully adjusted for age, sex, location (urban/rural), wealth index, education, smoking, waist-hip ratio, physical 
activity, history of diabetes, and daily intakes of energy (kcal), whole grains, vegetable and fruits, dairy, and red meats, with centre as random effect
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higher body mass index (P for interaction=0.043). 
We found similar associations between grains and 
events by geographical region and by sex (P for 
interaction>0.05). Mean systolic and diastolic blood 
pressure was significantly higher among participants 
with higher refined grain intake (supplementary tables 
S23-S25). For lipids, we found no clinically relevant 
differences in lipid concentrations with higher grain 
intake.
Table 5 shows the amount of macronutrient 
provided by white bread, whole wheat bread, 
cooked rice, and other intact grains. In the PURE 
study, we found white bread to be the main source 
of carbohydrates. Mean daily energy intake of PURE 
participants was about 2100 kcal/day, of which white 
bread was the main source. Because three servings 
of white bread contribute about 10% of total daily 
energy intake, we estimated the effect of a 10% 
table 3 | association between whole grain intake and clinical outcomes in participants (n=137 130) without baseline cardiovascular disease
Hazard ratio (95% ci)*
P for trend0 (n=31 686)† <50 g/d (n=45 112)‡ 50 to <100 g/d (n=17 016)§ ≥100 g/d (n=43 316)¶
composite events
No (%) events 2717 (8.6) 4484 (9.9) 1455 (8.6) 4012 (9.3)
Base model 1.15 (1.08 to 1.23) 1.08 (1.02 to 1.14) 1.04 (0.97 to 1.11) 1.00 (reference) <0.001
Minimally adjusted 1.04 (0.97 to 1.12) 1.02 (0.96 to 1.09) 1.05 (0.98 to 1.13) 1.00 (reference) 0.37
Fully adjusted 1.03 (0.96 to 1.10) 1.01 (0.95 to 1.08) 1.05 (0.98 to 1.13) 1.00 (reference) 0.59
Fully adjusted with medications 1.03 (0.96 to 1.11) 1.01 (0.95 to 1.08) 1.05 (0.98 to 1.13) 1.00 (reference) 0.57
total mortality
No (%) events 1518 (4.8) 2892 (6.4) 840 (4.9) 2571 (5.9)
Base model 1.17 (1.07 to 1.28) 1.06 (0.99 to 1.14) 0.99 (0.91 to 1.08) 1.00 (reference) <0.001
Minimally adjusted 0.99 (0.90 to 1.09) 0.96 (0.88 to 1.04) 1.01 (0.92 to 1.11) 1.00 (reference) 0.54
Fully adjusted 0.97 (0.88 to 1.07) 0.95 (0.87 to 1.03) 1.00 (0.91 to 1.11) 1.00 (reference) 0.37
Fully adjusted with medications 0.97 (0.88 to 1.07) 0.95 (0.87 to 1.03) 1.00 (0.91 to 1.10) 1.00 (reference) 0.37
non-cardiovascular mortality
No (%) events 1030 (3.3) 2023 (4.5) 570 (3.4) 1783 (4.1)
Base model 1.18 (1.07 to 1.31) 1.05 (0.96 to 1.14) 0.96 (0.86 to 1.06) 1.00 (reference) 0.003
Minimally adjusted 0.96 (0.86 to 1.08) 0.91 (0.83 to 1.00) 0.98 (0.87 to 1.09) 1.00 (reference) 0.25
Fully adjusted 0.94 (0.83 to 1.05) 0.89 (0.81 to 0.98) 0.96 (0.86 to 1.08) 1.00 (reference) 0.11
Fully adjusted with medications 0.94 (0.83 to 1.05) 0.89 (0.81 to 0.98) 0.96 (0.86 to 1.08) 1.00 (reference) 0.10
cardiovascular mortality
No (%) events 557 (1.8) 1008 (2.2) 300 (1.8) 912 (2.1)
Base model 1.17 (1.02 to 1.35) 1.09 (0.96 to 1.23) 1.03 (0.89 to 1.19) 1.00 (reference) 0.03
Minimally adjusted 1.06 (0.91 to 1.24) 1.06 (0.92 to 1.21) 1.02 (0.86 to 1.2) 1.00 (reference) 0.40
Fully adjusted 1.07 (0.91 to 1.26) 1.07 (0.93 to 1.23) 1.02 (0.87 to 1.21) 1.00 (reference) 0.34
Fully adjusted with medications 1.07 (0.91 to 1.26) 1.07 (0.93 to 1.23) 1.02 (0.86 to 1.21) 1.00 (reference) 0.33
Major cardiovascular disease
No (%) events 1618 (5.1) 2243 (5.0) 853 (5.0) 2184 (5.0)
Base model 1.11 (1.02 to 1.20) 1.05 (0.98 to 1.13) 1.06 (0.98 to 1.16) 1.00 (reference) 0.03
Minimally adjusted 1.04 (0.95 to 1.14) 1.04 (0.96 to 1.13) 1.07 (0.97 to 1.17) 1.00 (reference) 0.37
Fully adjusted 1.04 (0.95 to 1.14) 1.04 (0.96 to 1.13) 1.07 (0.97 to 1.17) 1.00 (reference) 0.41
Fully adjusted with medications 1.05 (0.95 to 1.15) 1.04 (0.96 to 1.12) 1.06 (0.97 to 1.17) 1.00 (reference) 0.38
Myocardial infarction
No (%) events 651 (2.1) 1038 (2.3) 392 (2.3) 918 (2.1)
Base model 1.12 (0.98 to 1.28) 1.03 (0.92 to 1.16) 1.12 (0.98 to 1.28) 1.00 (reference) 0.21
Minimally adjusted 1.12 (0.97 to 1.30) 1.09 (0.96 to 1.23) 1.14 (0.99 to 1.32) 1.00 (reference) 0.16
Fully adjusted 1.12 (0.97 to 1.31) 1.08 (0.95 to 1.23) 1.14 (0.99 to 1.32) 1.00 (reference) 0.18
Fully adjusted with medications 1.13 (0.97 to 1.31) 1.08 (0.95 to 1.23) 1.14 (0.99 to 1.32) 1.00 (reference) 0.18
stroke
No (%) events 852 (2.7) 950 (2.1) 383 (2.3) 1042 (2.4)
Base model 1.14 (1.01 to 1.27) 1.05 (0.94 to 1.16) 1.03 (0.91 to 1.16) 1.00 (reference) 0.04
Minimally adjusted 1.06 (0.93 to 1.20) 1.01 (0.90 to 1.13) 1.02 (0.90 to 1.16) 1.00 (reference) 0.44
Fully adjusted 1.05 (0.93 to 1.19) 1.00 (0.89 to 1.12) 1.01 (0.88 to 1.15) 1.00 (reference) 0.51
Fully adjusted with medications 1.06 (0.93 to 1.19) 1.00 (0.89 to 1.12) 1.01 (0.88 to 1.15) 1.00 (reference) 0.47
Heart failure
No (%) events 109 (0.3) 243 (0.5) 99 (0.6) 205 (0.5)
Base model 0.86 (0.65 to 1.14) 1.14 (0.91 to 1.44) 1.21 (0.93 to 1.56) 1.00 (reference) 0.53
Minimally adjusted 0.77 (0.56 to 1.06) 1.18 (0.92 to 1.53) 1.25 (0.94 to 1.66) 1.00 (reference) 0.30
Fully adjusted 0.75 (0.55 to 1.04) 1.19 (0.92 to 1.54) 1.27 (0.95 to 1.69) 1.00 (reference) 0.25
Fully adjusted with medications 0.76 (0.55 to 1.04) 1.19 (0.92 to 1.54) 1.27 (0.95 to 1.69) 1.00 (reference) 0.26
*Cox frailty model. Base model: adjusted for age and sex, with centre as random effect; minimally adjusted: adjusted for age, sex, location (urban/rural), wealth index, education, smoking, waist-
hip ratio, physical activity, history of diabetes, and daily intakes of energy (kcal), vegetable and fruits, dairy, and red meats, with centre as random effect; fully adjusted: adjusted as for minimally 
adjusted plus whole grains, with centre as random effect; fully adjusted with medications: adjusted as for fully adjusted plus medications (statins and antihypertensives), with centre as random 
effect.
†Median (interquartile range (IQR)) intake 0.0 (0.0-0.0).
‡Median (IQR) intake 17.3 (9.2-31.3).
§Median (IQR) intake 73.6 (62.0-84.2).
¶Median (IQR) intake 226.8(154.3-362.2).
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increase in refined carbohydrate consumption on 
risk of mortality and other outcomes. For every 200 
kcal increase in carbohydrate, the risk of mortality 
increased by about 3% (table 6). A 200 kcal increase 
through consumption of white bread was also 
associated with a higher risk of mortality.
discussion
In this large prospective study from 21 countries, 
we found that higher intakes of refined grains were 
associated with higher risks of mortality, non-
cardiovascular mortality, major cardiovascular 
disease, stroke, and composite outcomes. We did 
table 4 | association between white rice intake and clinical outcomes in participants (n=137 130) without baseline cardiovascular disease
Hazard ratio (95% ci)*
P for trend








≥450 g/d  
(n=31 216)**
composite events
No (%) events 3437 (9.0) 2826 (7.9) 1393 (8.6) 1436 (9.0) 3576 (11.5)
Base model 1.00 (reference) 0.89 (0.85 to 0.95) 0.84 (0.78 to 0.90) 0.84 (0.78 to 0.92) 0.79 (0.72 to 0.86) <0.001
Minimally adjusted 1.00 (reference) 1.00 (0.93 to 1.06) 0.97 (0.89 to 1.06) 0.95 (0.86 to 1.04) 0.87 (0.79 to 0.96) 0.01
Fully adjusted 1.00 (reference) 1.01 (0.94 to 1.07) 1.01 (0.93 to 1.11) 0.98 (0.89 to 1.08) 0.97 (0.86 to 1.08) 0.58
Fully adjusted with medications 1.00 (reference) 1.01 (0.95 to 1.08) 1.01 (0.92 to 1.11) 0.98 (0.89 to 1.08) 0.96 (0.86 to 1.08) 0.55
total mortality
No (%) events 2114 (5.6) 1698 (4.8) 784 (4.8) 867 (5.4) 2358 (7.6)
Base model 1.00 (reference) 0.85 (0.79 to 0.91) 0.77 (0.70 to 0.85) 0.81 (0.72 to 0.90) 0.77 (0.69 to 0.86) <0.001
Minimally adjusted 1.00 (reference) 0.95 (0.87 to 1.04) 0.89 (0.79 to 1.00) 0.91 (0.80 to 1.03) 0.81 (0.71 to 0.93) 0.004
Fully adjusted 1.00 (reference) 0.96 (0.88 to 1.05) 0.93 (0.82 to 1.05) 0.95 (0.83 to 1.08) 0.90 (0.78 to 1.04) 0.18
Fully adjusted with medications 1.00 (reference) 0.96 (0.89 to 1.05) 0.93 (0.82 to 1.05) 0.94 (0.83 to 1.07) 0.90 (0.78 to 1.04) 0.17
non-cardiovascular mortality
No (%) events 1527 (4.0) 1191 (3.3) 513 (3.2) 570 (3.6) 1605 (5.1)
Base model 1.00 (reference) 0.84 (0.77 to 0.91) 0.73 (0.65 to 0.83) 0.80 (0.70 to 0.91) 0.73 (0.64 to 0.83) <0.001
Minimally adjusted 1.00 (reference) 0.93 (0.84 to 1.03) 0.86 (0.74 to 0.99) 0.87 (0.75 to 1.01) 0.74 (0.63 to 0.86) <0.001
Fully adjusted 1.00 (reference) 0.94 (0.85 to 1.04) 0.90 (0.78 to 1.04) 0.91 (0.78 to 1.07) 0.82 (0.69 to 0.98) 0.05
Fully adjusted with medications 1.00 (reference) 0.94 (0.85 to 1.04) 0.90 (0.78 to 1.04) 0.91 (0.78 to 1.07) 0.82 (0.69 to 0.98) 0.05
cardiovascular mortality
No (%) events 659 (1.7) 605 (1.7) 319 (2.0) 338 (2.1) 856 (2.7)
Base model 1.00 (reference) 0.86 (0.76 to 0.97) 0.86 (0.74 to 1.01) 0.86 (0.72 to 1.02) 0.91 (0.76 to 1.08) 0.23
Minimally adjusted 1.00 (reference) 1.03 (0.89 to 1.19) 0.99 (0.82 to 1.2) 0.99 (0.81 to 1.21) 1.00 (0.81 to 1.24) 0.97
Fully adjusted 1.00 (reference) 1.04 (0.90 to 1.21) 1.03 (0.84 to 1.25) 1.02 (0.83 to 1.26) 1.09 (0.86 to 1.38) 0.59
Fully adjusted with medications 1.00 (reference) 1.05 (0.91 to 1.22) 1.02 (0.84 to 1.24) 1.02 (0.83 to 1.25) 1.09 (0.85 to 1.38) 0.62
Major cardiovascular disease
No (%) events 1925 (5.1) 1598 (4.5) 851 (5.2) 824 (5.1) 1700 (5.5)
Base model 1.00 (reference) 0.93 (0.86 to 1.00) 0.90 (0.81 to 0.99) 0.86 (0.77 to 0.95) 0.79 (0.70 to 0.89) <0.001
Minimally adjusted 1.00 (reference) 1.01 (0.93 to 1.10) 0.99 (0.89 to 1.11) 0.93 (0.82 to 1.05) 0.87 (0.76 to 0.99) 0.05
Fully adjusted 1.00 (reference) 1.02 (0.94 to 1.11) 1.04 (0.93 to 1.16) 0.98 (0.86 to 1.10) 0.97 (0.84 to 1.13) 0.70
Fully adjusted with medications 1.00 (reference) 1.03 (0.95 to 1.12) 1.03 (0.92 to 1.15) 0.97 (0.86 to 1.10) 0.97 (0.83 to 1.12) 0.63
Myocardial infarction
No (%) events 832 (2.2) 670 (1.9) 380 (2.3) 337 (2.1) 780 (2.5)
Base model 1.00 (reference) 0.92 (0.82 to 1.03) 0.98 (0.84 to 1.14) 0.82 (0.69 to 0.97) 0.72 (0.60 to 0.86) 0.001
Minimally adjusted 1.00 (reference) 0.99 (0.87 to 1.13) 1.07 (0.90 to 1.27) 0.86 (0.71 to 1.05) 0.84 (0.69 to 1.04) 0.10
Fully adjusted 1.00 (reference) 0.99 (0.87 to 1.13) 1.06 (0.89 to 1.27) 0.86 (0.70 to 1.04) 0.81 (0.64 to 1.02) 0.08
Fully adjusted with medications 1.00 (reference) 1.00 (0.87 to 1.14) 1.06 (0.89 to 1.26) 0.85 (0.70 to 1.04) 0.81 (0.64 to 1.02) 0.07
stroke
No (%) events 891 (2.3) 735 (2.1) 395 (2.4) 407 (2.5) 799 (2.6)
Base model 1.00 (reference) 0.90 (0.81 to 1.00) 0.81 (0.71 to 0.94) 0.85 (0.73 to 0.99) 0.81 (0.69 to 0.96) 0.008
Minimally adjusted 1.00 (reference) 0.96 (0.86 to 1.08) 0.90 (0.77 to 1.05) 0.91 (0.77 to 1.08) 0.85 (0.71 to 1.02) 0.09
Fully adjusted 1.00 (reference) 0.99 (0.88 to 1.11) 0.98 (0.83 to 1.15) 1.03 (0.86 to 1.22) 1.08 (0.88 to 1.33) 0.57
Fully adjusted with medications 1.00 (reference) 1.00 (0.89 to 1.12) 0.97 (0.83 to 1.14) 1.02 (0.85 to 1.21) 1.08 (0.87 to 1.32) 0.62
Heart failure
No (%) events 193 (0.5) 198 (0.6) 75 (0.5) 79 (0.5) 111 (0.4)
Base model 1.00 (reference) 1.20 (0.95 to 1.51) 1.11 (0.80 to 1.53) 1.14 (0.81 to 1.60) 1.03 (0.70 to 1.52) 0.75
Minimally adjusted 1.00 (reference) 1.44 (1.11 to 1.87) 1.26 (0.87 to 1.81) 1.28 (0.88 to 1.86) 1.00 (0.64 to 1.55) 0.73
Fully adjusted 1.00 (reference) 1.46 (1.120 to 1.89) 1.30 (0.90 to 1.88) 1.30 (0.89 to 1.91) 1.11 (0.69 to 1.78) 0.44
Fully adjusted with medications 1.00 (reference) 1.47 (1.13 to 1.92) 1.30 (0.90 to 1.87) 1.30 (0.89 to 1.90) 1.12 (0.70 to 1.79) 0.44
*Cox frailty model. Base model: adjusted for age and sex, with centre as random effect; minimally adjusted: adjusted for age, sex, location (urban/rural), wealth index, education, smoking, waist-
hip ratio, physical activity, history of diabetes, and daily intakes of energy (kcal), vegetable and fruits, dairy, and red meats, with centre as random effect; fully adjusted: adjusted as for minimally 
adjusted plus whole grains, with centre as random effect; fully adjusted with medications: adjusted as for fully adjusted plus medications (statins and antihypertensives), with centre as random 
effect.
†Median (interquartile range (IQR) intake) 20.0 (8.2-28.0).
‡Median (IQR) intake 84.6 (67.7-114.3).
§Median (IQR) intake 200 (171.4-214.3).
¶Median (IQR) intake 395.0 (327.5-400.0).
**Median (IQR) intake 863.1 (608.2-988.8).
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not find significant associations of consumption of 
whole grains or white rice with total mortality and 
cardiovascular outcomes.
comparison with other studies
The association of refined grains with outcomes of all 
cause and cause specific mortality has been explored 
previously. Schwingshackl et al,13 in a meta-analysis of 
four prospective studies with 11 034 mortality events, 
showed no association of high versus low intake of 
refined grains (intake range 0-183 g/day) with all 
cause mortality. The PURE study includes participants 
with a broad range of intakes, as it included countries 
across multiple regions. Previous cohort studies have 
shown an increased risk of coronary heart disease with 
higher intake of refined grains, and the association 
was observed in female participants.14 In a meta-
analysis involving 711 728 participants and 16 144 
events on the effects of refined grain including white 
rice, intake varied from 15 g to 540 g/day.11 Comparing 
high versus low intakes, this study reported a higher 
risk of coronary heart disease. Some previous studies 
have included white rice in the refined grain group, 
but we did not include rice in the refined grains group 
in PURE. The fact that a 200 kcal increase through the 
intake of white bread was associated with a greater risk 
of cardiovascular mortality in our population reaffirms 
the findings of our analyses.
Refined grains have lower dietary fibre content, 
vitamins and minerals, essential fatty acids, and 
phytochemicals, largely owing to loss of the outer bran 
layer and the endosperm of the grain being pounded 
during the process of refining. As a consequence of the 
refining process, rapid action by digestive enzymes 
and quick absorption from the small intestines could 
lead to an increase in post-prandial blood glucose 
concentrations.30 31 The rise in glucose concentrations 
increases the insulin concentrations, which leads 
to hypoglycaemia, lipolysis, and the stimulation of 
hunger and food intake.14 A review that investigated the 
association of bread intake with obesity and abdominal 
fat reported that reduction in white bread intake in a 
Mediterranean-style dietary pattern resulted in lower 
weight gain and abdominal fat gain. This might have 
happened as a result of a reduction in intake of a food 
with higher energy density and glycaemic index and 
lower dietary fibre,32 and higher consumption of fruits 
and vegetables.
When we did a meta-analysis of the PURE data by 
regions, the association of refined grains with clinical 
outcomes was apparent in China but not in other 
regions. This difference might have been due to the 
highest refined grain intakes in China compared with 
other regions, along with a wide range of intakes 
reported. Longitudinal trends have indicated an 
increase in consumption of refined grains in China.33 34 
A change from a traditional rice based pattern to a 
modern dietary pattern has been seen, which included 
increasing wheat intakes. Wheat intake in China has 
been steadily increasing over two decades (1991-
2011) and has been positively associated with risk of 
cardiovascular disease.35 The level of refinement of 
Composite events
  <50 (reference)
  50 to <150
  150 to <300
  300 to <450
  ≥450
Total mortality
  <50 (reference)
  50 to <150
  150 to <300
  300 to <450
  ≥450
Major cardiovascular disease
  <50 (reference)
  50 to <150
  150 to <300
  300 to <450
  ≥450
1.00 (1.00 to 1.00)
1.00 (0.92 to 1.10)
1.03 (0.92 to 1.15)
1.01 (0.90 to 1.13)
0.99 (0.87 to 1.13)
1.00 (1.00 to 1.00)
0.92 (0.81 to 1.03)
0.91 (0.79 to 1.05)
0.93 (0.79 to 1.09)
0.88 (0.74 to 1.05)
1.00 (1.00 to 1.00)
1.03 (0.92 to 1.14)
1.04 (0.91 to 1.19)
0.98 (0.85 to 1.14)
0.97 (0.82 to 1.15)








1.00 (1.00 to 1.00)
1.01 (0.92 to 1.12)
0.96 (0.81 to 1.15)
0.97 (0.81 to 1.16)
0.93 (0.52 to 1.67)
1.00 (1.00 to 1.00)
1.03 (0.91 to 1.16)
0.94 (0.74 to 1.20)
1.03 (0.82 to 1.29)
0.91 (0.37 to 2.25)
1.00 (1.00 to 1.00)
1.02 (0.89 to 1.16)
1.00 (0.80 to 1.24)
0.98 (0.78 to 1.22)
0.89 (0.43 to 1.83)






Fig 2 | association between white rice intake and clinical outcomes in asian (n=82 652) and non-asian countries (n=54 478). cox frailty model hazard 
ratios and 95% cis in model fully adjusted for age, sex, location (urban/rural), wealth index, education, smoking, waist-hip ratio, physical activity, 
history of diabetes, and daily intakes of energy (kcal), refined grains, whole grains, vegetable and fruits, dairy, and red meats, with centre as random 
effect.
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wheat and intake of refined wheat, however, has not 
been reported in previous studies.
We did not find a significant association between 
whole grain consumption and health outcomes. In the 
Atherosclerosis Risk in Communities (ARIC) study,36 
involving 11 940 people and 2539 events (total 
mortality 867; coronary artery disease 535; stroke 270), 
whole grain intakes were inversely associated with 
total mortality and incident coronary artery disease 
but not with stroke. Also, inverse associations of whole 
grain intake with total and cardiovascular mortality 
have been reported in a few meta-analyses7 9 12 37-42 
(the largest involving 1 041 692 participants and 
96 710 events). In the meta-analysis by Wei et al,7 
which included 816 599 participants and 89 251 
events, each three servings per day increase in whole 
grain intake was associated with 19% and 26% 
lower risk of mortality and cardiovascular mortality, 
respectively. Such associations were not evident in our 
study.
Several possible reasons exist for the lack of an 
association between whole grains and cardiovascular 
disease or mortality observed in our study. Firstly, no 
standard definition for whole grains exists, and the 
definition varies between countries. For example, the 
whole grain breads in different regions in Europe, North 
America, and South America have different amounts 
of whole grain added. Most products commercially 
available in retail stores that are termed whole grain 
foods are reconstituted or recombined to various 
extents.1 36 43 Secondly, whole grains pur portedly 
contain biologically active compounds, such as dietary 
fibre, vitamins, minerals, antioxidants, and other 
plant compounds such as lignans and phytosterols, 
which are removed during processing.14 43-45 
The health benefits are also attributed to their 
uniqueness in phytochemical composition, with some 
being in the bound (soluble, conjugated, or insoluble) 
form and others in the unbound or free form, with 
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Fig 3 | association between intake of refined grain (n=135 260), whole grain (n=135 096), and white rice (n=137 130) and clinical outcomes of 
composite events, total mortality, and major cardiovascular disease for every 50 g increase in intake. Multivariable fully adjusted model adjusted for 
age, sex, location (urban/rural), wealth index, education, smoking, waist-hip ratio, physical activity, history of diabetes, and daily intakes of energy 
(kcal), refined grains, whole grains, vegetable and fruits, dairy, and red meats, with centre as random effect
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activity, reducing oxidative stress.1 43 These biological 
compounds may affect cardiovascular risk by altering 
glucose homoeostasis, lipids and lipoproteins, 
endothelial function, and some other mechanisms.9 
The amount of these biological compounds may 
vary depending on the type of whole grains. Thirdly, 
plant genetics and a variety of agro-climatic factors 
influence the content of phytochemicals present in 
whole grains.43 Fourthly, the physiological mecha-
nism through which dietary carbohydrates influence 
health is thought to be via their effect on glycaemic 
responses,46 which vary by type of grain and particle 
size. This indicates that associations between whole 
grain intake and health outcomes are very complex and 
could be heterogeneous. Fifthly, whole grains are often 
consumed with sugar, negating much of the benefit of 
whole grains.45 In our study, which was conducted in 
21 countries, a variety of whole grains was consumed, 
and this may have obscured true associations with a 
specific form of whole grain.
A limited number of studies have examined the 
association of rice intake with total or cardiovascular 
mortality or cardiovascular events. A Japanese study 
showed a protective effect for cardiovascular disease, 
but only in men.47 By contrast, in a cohort of 117 366 
Chinese men and women, 40-74 years of age, with 
a mean follow-up of 9.8 years and 309 events, Yu et 
al reported a hazard ratio of 1.80 (95% confidence 
interval 1.01 to 3.17) for highest versus lowest 
quarter of intake of rice and refined wheat grain, as 
a combined category, for coronary heart disease.48 
In a recent meta-analysis (14 306 mortality events), 
an inverse association between consumption of rice 
and mortality among men (relative risk 0.87, 0.81 
to 0.94) and a positive association among women 
were reported.49 Two other meta-analysis (including 
207 556 to 1 777 059 participants and 12 391 to 
22 537 events) reported no associations between rice 
consumption and cardiovascular mortality.50 51 Muraki 
et al examined the association between white and 
brown rice consumption and risk of cardiovascular 
disease in three US cohorts and reported no 
association, similar to our findings.50 One probable 
reason for a higher risk of cardiovascular disease with 
higher rice intake was attributed to arsenic content in 
soil and during irrigation which is probably removed 
by polishing rice. Our study included participants from 
several countries where various varieties of rice were 
eaten. The composition of and physiological responses 
to different kinds of rice vary. Variations in glycaemic 
and insulinaemic responses have been reported, which 
could be due to differences in the characteristics of 
starch (for example, amylase to amylopectin ratio), in 
cultivated varieties, and in post-harvest technologies 
used, as well as the differences in cooking across 
the world.52 Another reason for the inconsistent 
association seen between rice consumption and 
outcomes may be the effect of complementary dishes 
that are consumed along with rice.49 Caution must 
be exercised, however, so that high intakes of rice are 
not advocated indiscriminately without ensuring that 
total carbohydrate intakes are within the limits of the 
acceptable macronutrient distribution range.
The reason for the different associations observed 
with refined grains and white rice is not clear. However, 
refined wheat is uniformly and rapidly digested 
and raises blood glucose, with none of the health 
advantages of fibre. Varieties of rice such as long grain 
rice and especially parboiled white rice may have 
both a definite glycaemic advantage and an overall 
nutritional advantage over refined wheat products. 
Also, depending on the culture and the nature of the 
rice eaten, rice may be displacing less desirable foods. 
Other differences in chemical composition and physical 
properties could exist, which might contribute to the 
associations seen.
strengths and limitations of study
Our study has some strengths and some potential 
limitations. With data from 21 countries across 
five continents being used for this analysis, diverse 
patterns of diet and a broad range of consumption have 
been characterised, and the results are likely to have 
wider generalisability than those of a study conducted 
in a single country. We considered extensive covariates 
during analysis. The addition of medications in the 
model did not change the results, indicating that our 
findings were robust. In addition to centre, location 
table 5 | cooked portions of grains and their relative percentage energy contribution as carbohydrate*
Foods Portion size (~100 g)
Per 100 g % energy consumption from  
carbohydrate in Pure populationenergy (kcal) carbohydrate (g) Water (g)
White bread 3-4 slices 263 49 36 35
Whole wheat bread 3-4 slices 240 41 39 11
Other whole grains, cooked 1 cup 160 18 78 8
White rice, cooked 0.5 cup 130 28 69 26
*Values taken from US Department of Agriculture National Nutrient Database for Standard Reference Legacy Release April 2018 (https://data.nal.usda.gov/dataset/usda-national-nutrient-
database-standard-reference-legacy-release).
table 6 | risk of mortality by 200 kcal increase in energy from various sources of carbohydrate
Foods (100 g) Portion size Hazard ratio (95% ci) P value
% energy from carbohydrate - 1.03 (1.00 to 1.05) <0.001
White bread 3 slices 1.05 (1.03 to 1.07) <0.001
Whole wheat bread 3 slices 1.01 (0.98 to 1.03) 0.15
Rice, cooked 1 cup 0.98 (0.96 to 1.00) 0.12
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(urban/rural), and income level of countries, we have 
controlled for variation in socioeconomic status by 
adjusting for education and wealth index, which 
are strong predictors of socioeconomic status (for 
example, deprivation or poverty), as countries at 
varying levels of nutrition transition (that is, shifts 
in diet and physical activity occurring because of 
demographic, economic, and epidemiological changes 
and globalisation) participated in the PURE study.
Although we recognise that desserts and pastries 
include both sugar and cereal grains, the sugar content 
was not accounted for in mixed dishes. Sweets, 
however, include other food groups in the recipe, so 
the effect of added sugars in cereal foods alone cannot 
be assessed. The intake of the various food groups 
by the categories of refined and whole grain intake 
(supplementary tables S26 and S27) does not indicate 
an increase in added sugar intake with increasing 
categories of intake. A similar pattern persisted for 
intake of the other food groups as well. With many 
known confounders accounted for, the observed 
associations might still be partly due to residual 
confounding factors. Furthermore, food frequency 
questionnaires do not capture absolute intakes, only 
relative intakes. However, dietary data collected in 
epidemiological studies provide estimates of food or 
nutrient intake that are useful for grouping individuals 
by their relative levels of intake of a food but not their 
absolute levels. This may underestimate the relation 
of diet and events. In PURE, diets were recorded 
comprehensively only at baseline and changes in diet 
may have occurred over the subsequent years. This 
would also tend to attenuate the associations with 
outcomes. However, in a previous analysis of PURE 
relating the consumption of fruits and vegetables 
to outcomes, similar associations were obtained by 
recording diet at baseline and at three years.17 In 
the PURE study, data were 99.5% complete for all 
variables, except for waist to hip ratio and physical 
activity. The completeness was 94% for waist to hip 
ratio and 93% for physical activity. We recognise that 
missingness may introduce bias, reduce power, and/
or affect the representativeness of the results. This is 
unlikely to be the case here, as the percentage with 
missing data was low for such large cohort study. We 
did a series of sensitivity analyses to check whether the 
missing data on these two covariates might have been 
non-random. Firstly, we excluded waist to hip ratio 
and physical activity from the multivariable models 
and found that the estimates for associations of refined 
grains, whole grains, and rice with outcomes were 
consistent. Additionally, we excluded the six countries 
that had missing data exceeding 10% on either of the 
two covariates and estimates were unchanged. This 
indicates that the missingness in our study had little 
effect on our results.
We acknowledge that repeated measures may 
improve precision of estimates, but we do not have 
repeated dietary measurements in PURE. Large 
observational studies have shown that four different 
approaches for analysing the association of dietary 
fats with coronary heart disease using repeated dietary 
measurements (baseline diet only, most recent diet, 
and two different algorithms for calculating cumulative 
average diets) yield substantively similar results.53 On 
the basis of these data by Hu et al, we are confident 
that over a relatively short follow-up (<10 years), the 
substantive estimates would not differ with repeated 
measures. A further limitation was that the dry weight 
of whole grain was approximately calculated for each 
region and not for each food item in the respective 
country items in the food list. We acknowledge this 
limitation, which might attenuate the association 
between whole grain and outcomes. Globally, however, 
we see that in the culture specific questionnaires, most 
whole grains are consumed in hydrated form as breads, 
pancake-like foods, and thick oat and maize porridges.
conclusions and policy implications
Our study from 21 countries showed that higher intake 
of refined grains was associated with higher risk of 
total mortality and major cardiovascular events. We 
observed no significant association between intake 
of whole grains or white rice and clinical outcomes. 
Intakes of a combination of cereal grains with a lower 
intake of refined wheat products should be encouraged 
while promoting a higher intake of whole grains. 
Reduction in quantity and improvement in quality of 
carbohydrate is essential for better health outcomes.
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